1. Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin-2-activated syngeneic bone marrow in mice;Agah;Cancer Res,1989
2. Generation and characterization of IL-2 activated bone marrow cells as a potent graft versus tumor effector in transplantation;Agah;J Immunol,1989
3. Role of lymphokineactivated killer cells as mediators of veto and natural suppression;Azuma;J Immunol,1988
4. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune reponse;Barth;Cancer Res,1989
5. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones;Bernhard;Int J Cancer,1994